  Pregabalin is currently approved for the treatment of epilepsy , generalized anxiety<symptom> disorder , neuropathic pain , and fibromyalgia. A qualitative study was undertaken in Jordan , where concerns have been raised about its unprescribed availability in community pharmacies and thereby its abuse. Semi-structured interviews were conducted with all patients with a history of pregabalin use in two Jordanian addiction treatment centers. All were male patients aged 21-30 years (